Biomark Diagnostics Inc (BUX.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 44 | 3 | 3 | 7 | 1 |
| Accounts receivable | 1 | -2 | -4 | -6 | -6 |
| Other Working Capital | 145 | -184 | -22 | 339 | -36 |
| Other Operating Activity | -248 | -176 | -284 | -203 | -188 |
| Operating Cash Flow | $-57 | $-358 | $-307 | $136 | $-229 |
| Cash Flows From Investing Activities | |||||
| Other Investing Activity | -59 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $-59 | $0 | $0 | $0 | $0 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | 0 | 20 |
| Debt Repayment | -220 | -3 | -3 | -3 | -1 |
| Other Financing Activity | 136 | 59 | 114 | 388 | 113 |
| Financing Cash Flow | $-83 | $56 | $111 | $384 | $132 |
| Beginning Cash Position | 379 | 682 | 878 | 357 | 455 |
| End Cash Position | 179 | 379 | 682 | 878 | 357 |
| Net Cash Flow | $-200 | $-302 | $-196 | $520 | $-97 |
| Free Cash Flow | |||||
| Operating Cash Flow | -57 | -358 | -307 | 136 | -229 |
| Free Cash Flow | -57 | -358 | -307 | 136 | -229 |